Form 8-K · Current report
KeyCorp 8-K, filed Oct 20, 2026
- Filed
- CIK
- 0000091576
- Accession no.
- 0000091576-26-000020
Summary
KeyCorp reported third-quarter 2026 net income from continuing operations attributable to common shareholders of $537 million, or $0.51 per diluted common share, up 24% year-over-year, on record revenue of $2.04 billion. Chairman and CEO Chris Gorman said the results support confidence in achieving and sustaining a return on tangible common equity of 15%+ by the end of 2027.
Key points
- KeyCorp reported third-quarter 2026 net income from continuing operations attributable to common shareholders of $537 million, or $0.51 per diluted common share.
- Total revenue was $2.04 billion, up 8% year-over-year and 4% sequentially, with a net interest margin of 2.95%.
- Average deposits increased $3.6 billion sequentially while average loans held for investment increased $1.5 billion, and investment banking and debt placement fees rose 27% sequentially.
- The Common Equity Tier 1 ratio was an estimated 11.1%, and KeyCorp repurchased $320 million of common shares during the quarter.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. On October 20, 2026, KeyCorp issued a press release announcing its financial results for the three- and nine-month periods ended September 30, 2026 (the “Press Release”), and posted on its website its third quarter 2026 Supplemental Information Package (the “Supplemental Information Package”). The Press Release and Supplemental Information Package are being furnished as Exhibit 99.1 and Exhibit 99.2, respectively. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.